| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
73,500,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Nuvalent is a biopharmaceutical company. Co.'s product candidate, NVL-520, is a ROS proto-oncogene 1 (ROS1)-selective inhibitor designed with the aim to address the clinical challenges of emergent treatment resistance, central nervous system (CNS)-related adverse events, and brain metastases that may limit the use of available ROS1 tyrosine kinase inhibitors. Co.'s another product candidate, NVL-655, is a brain-penetrant anaplastic lymphoma kinase (ALK)-selective inhibitor, designed with the aim to address the clinical challenges of emergent treatment resistance, CNS-related adverse events, and brain metastases that may limit the use of first-, second-, and third-generation ALK inhibitors.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
1,089,349 |
1,250,019 |
2,749,015 |
6,488,173 |
| Total Sell Value |
$103,220,552 |
$115,966,047 |
$244,862,036 |
$570,858,987 |
| Total People Sold |
7 |
7 |
9 |
11 |
| Total Sell Transactions |
28 |
43 |
65 |
124 |
| End Date |
2025-09-11 |
2025-06-10 |
2024-12-10 |
2023-12-11 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Noci Darlene |
Chief Development Officer |
• – – |
2025-11-28 |
4 |
AS |
$107.85 |
$434,319 |
D/D |
(4,000) |
48,034 |
|
- |
|
| Noci Darlene |
Chief Development Officer |
• – – |
2025-11-28 |
4 |
OE |
$27.85 |
$111,400 |
D/D |
4,000 |
52,034 |
|
- |
|
| Shair Matthew |
|
– • – |
2025-11-24 |
4 |
AS |
$107.70 |
$180,460 |
I/I |
(1,650) |
201,672 |
|
- |
|
| Shair Matthew |
|
– • – |
2025-11-24 |
4 |
AS |
$107.70 |
$639,814 |
D/D |
(5,850) |
1,377,194 |
|
- |
|
| Deerfield Private Design Fund Iv, L.p. |
Director by Deputization |
– • • |
2025-11-24 |
4 |
S |
$95.45 |
$70,874,975 |
I/I |
(742,574) |
8,299,225 |
|
- |
|
| Balcom Alexandra |
Chief Financial Officer |
• – – |
2025-11-18 |
4 |
AS |
$103.61 |
$76,005 |
D/D |
(729) |
61,734 |
|
- |
|
| Balcom Alexandra |
Chief Financial Officer |
• – – |
2025-11-18 |
4 |
OE |
$72.35 |
$52,743 |
D/D |
729 |
62,463 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2025-11-17 |
4 |
AS |
$105.16 |
$2,552,999 |
D/D |
(24,200) |
49,086 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2025-11-17 |
4 |
OE |
$6.89 |
$166,738 |
D/D |
24,200 |
73,286 |
|
- |
|
| Balcom Alexandra |
Chief Financial Officer |
• – – |
2025-11-17 |
4 |
AS |
$93.80 |
$1,989,025 |
D/D |
(20,000) |
61,734 |
|
- |
|
| Balcom Alexandra |
Chief Financial Officer |
• – – |
2025-11-17 |
4 |
OE |
$6.89 |
$996,963 |
D/D |
20,000 |
81,734 |
|
- |
|
| Noci Darlene |
Chief Development Officer |
• – – |
2025-10-30 |
4 |
AS |
$98.91 |
$411,661 |
D/D |
(4,000) |
48,034 |
|
- |
|
| Noci Darlene |
Chief Development Officer |
• – – |
2025-10-30 |
4 |
OE |
$27.85 |
$111,400 |
D/D |
4,000 |
52,034 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2025-10-30 |
4 |
AS |
$96.65 |
$2,248,943 |
D/D |
(21,800) |
49,086 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2025-10-30 |
4 |
OE |
$6.89 |
$150,202 |
D/D |
21,800 |
70,886 |
|
- |
|
| Shair Matthew |
|
– • – |
2025-10-28 |
4 |
AS |
$100.27 |
$917,872 |
I/I |
(9,154) |
203,322 |
|
- |
|
| Shair Matthew |
|
– • – |
2025-10-28 |
4 |
AS |
$100.27 |
$3,254,263 |
D/D |
(32,455) |
1,383,044 |
|
- |
|
| Shair Matthew |
|
– • – |
2025-10-27 |
4 |
AS |
$100.23 |
$405,531 |
I/I |
(4,046) |
212,476 |
|
- |
|
| Shair Matthew |
|
– • – |
2025-10-27 |
4 |
AS |
$100.23 |
$1,437,799 |
D/D |
(14,345) |
1,415,499 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2025-10-20 |
4 |
AS |
$94.91 |
$474,550 |
D/D |
(5,000) |
49,086 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2025-10-20 |
4 |
OE |
$6.89 |
$34,450 |
D/D |
5,000 |
54,086 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2025-10-16 |
4 |
AS |
$90.54 |
$1,134,442 |
D/D |
(12,376) |
49,086 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2025-10-16 |
4 |
OE |
$6.89 |
$85,271 |
D/D |
12,376 |
61,462 |
|
- |
|
| Porter James Richard |
President and CEO |
• • – |
2025-10-16 |
4 |
AS |
$90.01 |
$2,447,021 |
D/D |
(27,000) |
249,062 |
|
- |
|
| Porter James Richard |
President and CEO |
• • – |
2025-10-16 |
4 |
OE |
$18.93 |
$511,110 |
D/D |
27,000 |
276,062 |
|
- |
|
359 Records found
|
|
Page 1 of 15 |
|
|
